No-regret #hydrogen:
Charting early steps for H₂ infrastructure in Europe.

👉Summary of conclusions of a new study by @AgoraEW @AFRY_global @Ma_Deutsch @gnievchenko (1/17)
https://t.co/YA50FA57Em

The idea behind this study is that future hydrogen demand is highly uncertain and we don’t want to spend tens of billions of euros to repurpose a network which won’t be needed. For instance, hydrogen in ground transport is a hotly debated topic https://t.co/RlnqDYVzpr (2/17)
Similar things can be said about heat. 40% of today’s industrial natural gas use in the EU goes to heat below 100°C and therefore is within range of electric heat pumps – whose performance factors far exceed 100%. (3/17)
Even for higher temperatures, a range of power-to-heat (PtH) options can be more energy-efficient than hydrogen and should be considered first. Available PtH technologies can cover all temperature levels needed in industrial production (e.g. electric arc furnace: 3500°C). (4/17)
In our view, hydrogen use for feedstock and chemical reactions is the only inescapable source of industrial hydrogen demand in Europe that does not lend itself to electrification. Examples include ammonia, steel, and petrochemical industries. (5/17)
We see strong demand for hydrogen from steel in particular as producers all over Europe (🇸🇪🇷🇴🇩🇪🇦🇹🇮🇹🇫🇷) plan to move to direct reduced iron (DRI) processes – and so do others around the globe, as recent announcements from China and Korea have shown. (6/17)
Given the 2050 climate neutrality target, we see the demand from refineries vanish, to be replaced with demand from steel. Overall, by 2050 we expect that almost 300 TWh of low-carbon hydrogen will be required. Remarkably, that is similar to hydrogen demand in 2020. (7/17)
Having established inescapable demand, we can start thinking about matching supply. European and neighbouring countries have a high renewable energy potential that can be tapped for direct-electric applications and renewable hydrogen production. (8/17)
In our analysis, we consider two scenarios with renewable hydrogen production: The BLUE-GREEN scenario also includes SMRCCS as an option in 🇳🇱🇳🇴🇬🇧because those countries are actively developing the technology. (9/17)
Taking into account asset lifecycles and political commitments in the BLUE-GREEN scenario, fossil-based hydrogen with carbon capture will remain a viable investment until the 2030s. However, … (10/17)
… strong policies for renewable hydrogen will shorten the investment window for fossil hydrogen, likely closing it before the end of the 2020s as is the outcome of the FAST GREEN scenario which is in line with EU Hydrogen strategy electrolyser targets. (11/17)
But producing the required quantities of H2, especially with renewables, is only one piece of the puzzle. Geography adds to the challenge: steel, ammonia, refineries and chemical plants are widely distributed across Europe. Their demand can vary by an order of magnitude. (12/17)
Ensuring reliable supply means accounting for various weather and seasonal effects. In our analysis, we model salt caverns to take care of the variation in renewables to produce “flat hydrogen”. That led us to derive least-cost pipeline corridors for hydrogen transport. (13/17)
Consequently, we identify 4 robust no-regret corridors for early hydrogen pipelines and storage based on industrial demand in different parts of Europe. The demand identified is unlikely to justify a large, pan-European H2 backbone. (14/17)
We do note, however, that our assumptions are limited to inescapable demand from industry. Adding potential hydrogen demand from power, aviation and shipping sectors is likely to strengthen the case for a more expansive network of H2 pipelines. (15/17)
Nonetheless, even under most optimistic scenarios any future H2 network will be smaller than the current natgas network. A no-regret vision for H2 infrastructure reduces the risk of oversizing by focusing on inescapable demand, robust green hydrogen corridors and storage. (16/17)
You can access the underlying maps and data here: (17/17)

https://t.co/5W7hyqGOIg

More from Health

1/16
Why do B12 and folate deficiencies lead to HUGE red blood cells?

And, if the issue is DNA synthesis, why are red blood cells (which don't have DNA) the key cell line affected?

For answers, we'll have to go back a few billion years.


2/
RNA came first. Then, ~3-4 billion years ago, DNA emerged.

Among their differences:
🔹RNA contains uracil
🔹DNA contains thymine

But why does DNA contains thymine (T) instead of uracil (U)?

https://t.co/XlxT6cLLXg


3/
🔑Cytosine (C) can undergo spontaneous deamination to uracil (U).

In the RNA world, this meant that U could appear intensionally or unintentionally. This is clearly problematic. How can you repair RNA when you can't tell if something is an error?

https://t.co/bIZGviHBUc


4/
DNA's use of T instead of U means that spontaneous C → U deamination can be corrected without worry that an intentional U is being removed.

DNA requires greater stability than RNA so the transition to a thymine-based structure was beneficial.

https://t.co/bIZGviHBUc


5/
Let's return to megaloblastic anemia secondary to B12 or folate deficiency.

When either is severely deficient deoxythymidine monophosphate (dTMP*) production is hindered. With less dTMP, DNA synthesis is abnormal.

[*Note: thymine is the base in dTMP]

https://t.co/AnDUtKkbZh
On 18.12.2020, computer engineer @FitTuber shared @YouTube video titled "10 Safe & Useful Ayurvedic Tablets to Replace Allopathic Pills (Instant Relief)". The drugs he promoted were by @baidyanathgroup, not sure if it was paid promotion. I bought them:
https://t.co/w6Sh2pMvJf


10 drugs, details, batch numbers R given in pic👇. All by @baidyanathgroup exept 1 by https://t.co/tg46sBhJr2
We did GCMSMS, ICP-OES and FTIR analyses on these samples. Here are my 10 safer modern medicine alternatives 2 @FitTuber's untested, potentially harmful #Ayurvedic drugs


Kanthsudharak Vati by Unjha Pharma
@FitTuber: 4 sorethroat, cold, cough
Analysis: Lead 0.54 mg/kg, Cadmium 0.4 mg/kg, Thallium 0.71 mg/kg and industrial phenols.
Low values, but not ideal.

Safe alternative: Levocetrizine & non-sedative cough syrup Levodropropizine


Baidyanath Rajbati
@Fittuber: for bloating, gas
Analysis:
Mercury 1.2 mg/kg
Arsenic 2.25 mg/kg
Male anabolic hormone - hydroxy testosterone+
Curcumin
Talc powder

Safer alternative: activated charcoal+simethicone (non-absorbed, no side effects) or short course esomeprazole.


Baidyanath Bilwadi Choorna
@Fittuber - 4 diarrhoea
Analysis
Thallium 3.68 mg/kg
[fun fact: 10-15 mg/kg is lethal dose for humans. Death can occur at lower dosages] https://t.co/9ozOKROhCK
Fenretinide - synthetic anti-cancer drug
Liver toxic chromium phosph.

Safer: Racecadotril
I think @SamAdlerBell in his quest to be the contrarian on Fauci gets several things wrong here. 1/


First, the failure last year actually was driven by the White House, the #Trump inner circle. Watch what's happening now, the US' scientific and public health infrastructure is creaking back to life. 2/

I think Sam underestimates the decimation of many of our health agencies over the past four years and the establishment of ideological control over them during the pandemic. 3/

I also am puzzled why Tony gets the blame for not speaking up, etc. Robert Redfield, Brett Giroir, Deb Birx, Jerome Adams, Alex Azar all could have done the same. 4/

Several of these people Bob Redfield, Brett Giroir, Alex Azar were led by craven ambition, Jerome Adams by cowardice, but I do think Deb Birx and Tony tried as institutionalists, insiders to make a difference. 5/

You May Also Like

I’m torn on how to approach the idea of luck. I’m the first to admit that I am one of the luckiest people on the planet. To be born into a prosperous American family in 1960 with smart parents is to start life on third base. The odds against my very existence are astronomical.


I’ve always felt that the luckiest people I know had a talent for recognizing circumstances, not of their own making, that were conducive to a favorable outcome and their ability to quickly take advantage of them.

In other words, dumb luck was just that, it required no awareness on the person’s part, whereas “smart” luck involved awareness followed by action before the circumstances changed.

So, was I “lucky” to be born when I was—nothing I had any control over—and that I came of age just as huge databases and computers were advancing to the point where I could use those tools to write “What Works on Wall Street?” Absolutely.

Was I lucky to start my stock market investments near the peak of interest rates which allowed me to spend the majority of my adult life in a falling rate environment? Yup.